Eli Lilly (NYSE:LLY) and Johnson & Johnson (NYSE:JNJ) just reported Q1 2026 results that read like two different playbooks ...
Dave Ricks steered the 150-year-old drug giant to a $1 trillion market cap. Can he defeat pharma’s boom and bust cycle?
LCCC is launching a hands-on training pipeline that places technicians directly into the pharmaceutical industry.
Exclusive: STAT has learned that Eli Lilly and the FDA allowed a 79-year-old to gain extraordinary access to an experimental ...
5don MSN
Eli Lilly Is Dominating the GLP-1 Market: Here's What a $5,000 Investment Could Look Like in 5 Years
The weight loss tailwind isn't about to come to a halt.
Indianapolis-based Eli Lilly reportedly gave an unidentified 79-year-old man exclusive access to its experimental obesity and ...
The rumor stems from a report claiming an unnamed 79-year-old man received access to the drug earlier this year.
The Medicare GLP-1 Bridge may hold the key to Eli Lilly's market share.
Who got exclusive access to Eli Lilly's highly anticipated obesity candidate? And why are drugmakers spending so much on ...
The GLP-1 maker’s latest AI investment targets drug discovery and the future of consumer medicine.
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. The Eli Lilly logo appears on a laptop computer screen in this photo illustration in Athens, ...
By Maggie Fick BRUSSELS, June 23 (Reuters) - Eli Lilly expects to launch its weight-loss pill in Europe and Britain in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results